Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes.
Division of Respiratory and Critical Care Medicine, National University Hospital, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: pyng_lee@nuhs.edu.sg.
Pyng
P
Lee
D002408:Catheters, Indwelling; D003362:Cost-Benefit Analysis; D006801:Humans; D016066:Pleural Effusion, Malignant / Q000628:therapy*; D018700:Pleurodesis / Q000191:economics / Q000379:methods*; D011788:Quality of Life; D012008:Recurrence; D013627:Talc / Q000008:administration & dosage*; D013906:Thoracoscopy / Q000191:economics / Q000379:methods*; D013907:Thoracostomy; D016896:Treatment Outcome
D013627:Talc